Clay-based hemostatic agents and devices for the delivery thereof
View Patent ↗A device for promoting the clotting of blood comprises a clay material in particle form and a receptacle for containing the clay material. At least a portion of the receptacle is defined by a mesh. Another device comprises a gauze substrate and a clay material disposed on the gauze substrate. Another device is a bandage comprising a substrate, a mesh mounted on the substrate, and particles of a clay material retained in the mesh. A hemostatic sponge comprises a substrate, a hemostatic material disposed on a first surface of the substrate, and a release agent disposed on a second surface of the substrate. The release agent is disposed on the wound-contacting surface of the substrate. When treating a bleeding wound, application of the hemostatic sponge causes at least a portion of the hemostatic material to come into contact with blood through the release agent and through the substrate.
1. A device capable of providing a hemostatic effect on bleeding, said device comprising:
a gauze substrate;
a clay material disposed on said gauze substrate; and
polyvinyl alcohol binder disposed on said gauze substrate to bind said clay material to said gauze substrate;
wherein the gauze substrate initially exists separately from the clay; and
wherein said device is configured such that when treating bleeding, application of said device is capable of causing at least a portion of said clay material to come into contact with blood to assist in accelerating clotting.
2. The device of claim 1 , wherein said clay material comprises kaolin.
3. The device of claim 1 , wherein said clay material comprises a material selected from the group consisting of attapulgite, bentonite, kaolin, and combinations of the foregoing materials.
4. The device of claim 1 , further comprising diatomaceous earth disposed on said gauze substrate.
5. The device of claim 1 , wherein said clay material further comprises a material selected from the group consisting of magnesium sulfate, sodium metaphosphate, calcium chloride, dextrin, hydrates of the foregoing materials, and combinations of the foregoing materials.
6. The device of claim 1 , wherein said clay material further comprises a pharmaceutically-active composition selected from the group consisting of antibiotics, antifungal agents, antimicrobial agents, anti-inflammatory agents, analgesics, antihistamines, compounds containing silver or copper ions, and combinations of the foregoing compositions.
7. The device of claim 1 , wherein said gauze substrate is fabricated from a material selected from the group consisting of cotton, silk, wool, plastic, cellulose, rayon, polyester, and combinations of the foregoing.
8. The device of claim 1 , wherein said gauze substrate is flexible to allow said gauze substrate to form to a shape of said bleeding wound and to retain a shape of said bleeding wound.
9. A hemostatic cloth, comprising:
a fabric substrate;
a hemostatic material disposed on said fabric substrate; and
polyvinyl alcohol binder disposed on said fabric substrate to bind said hemostatic material to said fabric substrate;
wherein the fabric substrate initially exists separately from the clay; and
wherein said cloth is configured such that when treating bleeding, application of said hemostatic cloth is capable of causing at least a portion of said hemostatic material to come into contact with blood to assist in accelerating clotting.
10. The hemostatic cloth of claim 9 , wherein said fabric substrate comprises at least one of woven strands and unwoven strands.
11. The hemostatic cloth of claim 9 , wherein said fabric substrate comprises a felt.
12. The hemostatic cloth of claim 9 , wherein said hemostatic material comprises a material selected from the group consisting of clays, silica-based material, diatomaceous earth, chitosan, and combinations of the foregoing.
13. A hemostatic sponge, comprising:
a substrate;
a hemostatic material disposed on a first surface of said substrate;
polyvinyl alcohol binder disposed on said first surface of the substrate to bind said hemostatic material to said substrate;
and a release agent disposed on a second surface of said substrate;
wherein the substrate initially exists separately from the hemostatic material.
14. The hemostatic sponge of claim 13 , wherein said substrate comprises a material selected from the group consisting of cotton, rayon/polyester cellulose blends, cellulose, paper, and combinations of the foregoing.
15. The hemostatic sponge of claim 13 , wherein said hemostatic material comprises kaolin.
16. The hemostatic sponge of claim 13 , wherein said hemostatic material comprises a material selected from the group consisting of attapulgite clay, bentonite clay, kaolin clay, bioactive glass, biological hemostats, diatomaceous earth, and combinations of the foregoing.
17. The hemostatic sponge of claim 13 , further comprising a binder to adhere said hemostatic material to said substrate.
18. The hemostatic sponge of claim 17 , wherein said binder is chitosan or polyvinyl alcohol.
19. The hemostatic sponge of claim 13 , wherein said release agent is selected from the group consisting of polyvinyl alcohol, silicone, and gelatinized starch.
20. The hemostatic sponge of claim 13 , further comprising at least one of water and alcohol.
21. The hemostatic sponge of claim 13 , further comprising a radioopaque agent.